Kezar Life Sciences, Inc.

KZR | NASDAQ | 0 Sledující

$4.72

-1.46%

-$0.07

Sledovat

Overview Metrics Financials

Breakdown	12/31/2024 USD	12/31/2023 USD	12/31/2022 USD	12/31/2021 USD
Total revenue	0 -100.00%	7,000 -	0 -	0 -
Cost of revenue	0 -100.00%	1,066 +4.20%	1,023 -32.25%	1,510 -
Gross profit	0 -100.00%	5,934 +680.06%	-1,023 +32.25%	-1,510 -
Operating expense	90,605 -23.49%	118,424 +66.41%	71,162 +30.19%	54,659 -
Operating income	-90,605 +13.90%	-105,237 -47.88%	-71,162 -30.19%	-54,659 -
Pretax Income	-83,736 +17.80%	-101,870 -49.28%	-68,239 -24.91%	-54,630 -
Tax Provision	0 -	0 +100.00%	-2,923 -116.36%	-1,351 -
Net income	-83,736 +17.80%	-101,870 -55.96%	-65,316 -22.59%	-53,279 -
EPS	-1.15 +17.86%	-1.4 -44.33%	-0.97 +3.96%	-1.01 -
Diluted EPS	-1.15 +17.86%	-1.4 -44.33%	-0.97 +3.96%	-1.01 -
Average Shares	72,902 +0.48%	72,554 +7.70%	67,369 +27.69%	52,759 -
Diluted Average Shares	72,902 +0.48%	72,554 +7.70%	67,369 +27.69%	52,759 -
EBIT	-85,329 +14.94%	-100,320 -49.43%	-67,133 -23.25%	-54,471 -
EBITDA	-90,605 +8.71%	-99,254 -50.13%	-66,110 -24.83%	-52,961 -

Soubory cookie používáme ke zlepšení prohlížení na webu.